182 related articles for article (PubMed ID: 38051092)
1. Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants.
Collard R; Majtan T
Mol Cell Biol; 2023; 43(12):664-674. PubMed ID: 38051092
[TBL] [Abstract][Full Text] [Related]
2. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70.
Singh LR; Gupta S; Honig NH; Kraus JP; Kruger WD
PLoS Genet; 2010 Jan; 6(1):e1000807. PubMed ID: 20066033
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two pathogenic mutations in cystathionine beta-synthase: different intracellular locations for wild-type and mutant proteins.
Casique L; Kabil O; Banerjee R; Martinez JC; De Lucca M
Gene; 2013 Nov; 531(1):117-24. PubMed ID: 23981774
[TBL] [Abstract][Full Text] [Related]
4. Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate.
Melenovská P; Kopecká J; Krijt J; Hnízda A; Raková K; Janošík M; Wilcken B; Kožich V
J Inherit Metab Dis; 2015 Mar; 38(2):287-94. PubMed ID: 25331909
[TBL] [Abstract][Full Text] [Related]
5. Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria.
Majtan T; Pey AL; Gimenez-Mascarell P; Martínez-Cruz LA; Szabo C; Kožich V; Kraus JP
Handb Exp Pharmacol; 2018; 245():345-383. PubMed ID: 29119254
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions.
Majtan T; Pey AL; Ereño-Orbea J; Martínez-Cruz LA; Kraus JP
Curr Drug Targets; 2016; 17(13):1455-70. PubMed ID: 26931358
[TBL] [Abstract][Full Text] [Related]
7. Functional rescue of mutant human cystathionine beta-synthase by manipulation of Hsp26 and Hsp70 levels in Saccharomyces cerevisiae.
Singh LR; Kruger WD
J Biol Chem; 2009 Feb; 284(7):4238-45. PubMed ID: 19074437
[TBL] [Abstract][Full Text] [Related]
8. Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: purification and characterization of eight CBS mutant enzymes.
Majtan T; Liu L; Carpenter JF; Kraus JP
J Biol Chem; 2010 May; 285(21):15866-73. PubMed ID: 20308073
[TBL] [Abstract][Full Text] [Related]
9. Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.
Gupta S; Wang L; Anderl J; Slifker MJ; Kirk C; Kruger WD
Hum Mutat; 2013 Aug; 34(8):1085-93. PubMed ID: 23592311
[TBL] [Abstract][Full Text] [Related]
10. Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones.
Kopecká J; Krijt J; Raková K; Kožich V
J Inherit Metab Dis; 2011 Feb; 34(1):39-48. PubMed ID: 20490928
[TBL] [Abstract][Full Text] [Related]
11. Examination of two different proteasome inhibitors in reactivating mutant human cystathionine β-synthase in mice.
Gupta S; Lee HO; Wang L; Kruger WD
PLoS One; 2023; 18(6):e0286550. PubMed ID: 37319242
[TBL] [Abstract][Full Text] [Related]
12. Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria.
Majtan T; Kožich V; Kruger WD
Br J Pharmacol; 2023 Feb; 180(3):264-278. PubMed ID: 36417581
[TBL] [Abstract][Full Text] [Related]
13. Reduced response of Cystathionine Beta-Synthase (CBS) to S-Adenosylmethionine (SAM): Identification and functional analysis of CBS gene mutations in Homocystinuria patients.
Mendes MI; Colaço HG; Smith DE; Ramos RJ; Pop A; van Dooren SJ; Tavares de Almeida I; Kluijtmans LA; Janssen MC; Rivera I; Salomons GS; Leandro P; Blom HJ
J Inherit Metab Dis; 2014 Mar; 37(2):245-54. PubMed ID: 23974653
[TBL] [Abstract][Full Text] [Related]
14. Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine β-synthase (
Gupta S; Kelow S; Wang L; Andrake MD; Dunbrack RL; Kruger WD
J Biol Chem; 2018 Sep; 293(36):13921-13931. PubMed ID: 30030379
[TBL] [Abstract][Full Text] [Related]
15. How to fix a broken protein: restoring function to mutant human cystathionine β-synthase.
Kruger WD
Hum Genet; 2022 Jul; 141(7):1299-1308. PubMed ID: 34636997
[TBL] [Abstract][Full Text] [Related]
16. In silico and in vivo models for Qatari-specific classical homocystinuria as basis for development of novel therapies.
Ismail HM; Krishnamoorthy N; Al-Dewik N; Zayed H; Mohamed NA; Giacomo VD; Gupta S; Häberle J; Thöny B; Blom HJ; Kruger WD; Ben-Omran T; Nasrallah GK
Hum Mutat; 2019 Feb; 40(2):230-240. PubMed ID: 30408270
[TBL] [Abstract][Full Text] [Related]
17. Kinetic stability of cystathionine beta-synthase can be modulated by structural analogs of S-adenosylmethionine: Potential approach to pharmacological chaperone therapy for homocystinuria.
Majtan T; Pey AL; Kraus JP
Biochimie; 2016 Jul; 126():6-13. PubMed ID: 26805382
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model.
Wang L; Chen X; Tang B; Hua X; Klein-Szanto A; Kruger WD
Hum Mol Genet; 2005 Aug; 14(15):2201-8. PubMed ID: 15972722
[TBL] [Abstract][Full Text] [Related]
19. Human cystathionine β-synthase (CBS) contains two classes of binding sites for S-adenosylmethionine (SAM): complex regulation of CBS activity and stability by SAM.
Pey AL; Majtan T; Sanchez-Ruiz JM; Kraus JP
Biochem J; 2013 Jan; 449(1):109-21. PubMed ID: 22985361
[TBL] [Abstract][Full Text] [Related]
20. Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria.
Janosík M; Oliveriusová J; Janosíková B; Sokolová J; Kraus E; Kraus JP; Kozich V
Am J Hum Genet; 2001 Jun; 68(6):1506-13. PubMed ID: 11359213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
